Descrizione Clinica
Alkalos 2fl 60cpr muscle supplements
ALKALOS
Description
Calcium citrate supplement, magnesium, potassium bicarbonate and vitamin D3. Calcium and vitamin D3 contribute to the well-being of bones.
Ingredients
Unit A: Citrate Calcium, Vitamin D3 (colycalciferol). Unit B: Magnesium Citrate, Potassium Citrate.
Nutritional characteristics
Mode of use
It is recommended to take 1 tablet A in the morning and 1 tablet B in the evening before bedtime.
Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under 3 years of age.
Supplements should not be understood as substitutes for a varied diet.
Contraindicated in patients suffering from hyperkaliemia or hypermagnesemia, or conditions that may predispose of such plasma alterations. These conditions include chronic kidney failure, uncontrolled diabetes mellitus.
The contemporary intake of ALKALOS and potassium-saving drugs (triamterene, spironolactone, amiloride) could determine hyperkaliemia. It is therefore recommended to monitor the performance of kaliemia. There are no known interactions with other drugs.
Rarely, during treatment, mild gastrointestinal disorders such as: abdominal heaviness, nausea and occasionally diarrhea.
The package in tablets can be particularly indicated in these subjects.
Conservation
Deadline for storage from the date of production, in integral packaging: 24 months.
Format
The package contains:
- 1 bottle of 60 tablets A
- 1 bottle of 60 tablets B.
Cod. 01016
Calcium citrate supplement, magnesium, potassium bicarbonate and vitamin D3. Calcium and vitamin D3 contribute to the well-being of bones.
Ingredients
Unit A: Citrate Calcium, Vitamin D3 (colycalciferol). Unit B: Magnesium Citrate, Potassium Citrate.
Nutritional characteristics
| Average values | for 1 tablet A | 1 tablet B |
| Calcium Citrate | 1.180 mg (equal to 250 mg calcium) | - |
| Vitamin D3 | 7.5 mcg | - |
| Potassium Citrate | - | 715 mg (274 mg potassium) |
| Magnesium Citrate | - | 263 mg (equal to 42.5 mg of magnesium) |
Mode of use
It is recommended to take 1 tablet A in the morning and 1 tablet B in the evening before bedtime.
Warnings
Do not exceed the recommended daily dose.
Keep out of reach of children under 3 years of age.
Supplements should not be understood as substitutes for a varied diet.
Contraindicated in patients suffering from hyperkaliemia or hypermagnesemia, or conditions that may predispose of such plasma alterations. These conditions include chronic kidney failure, uncontrolled diabetes mellitus.
The contemporary intake of ALKALOS and potassium-saving drugs (triamterene, spironolactone, amiloride) could determine hyperkaliemia. It is therefore recommended to monitor the performance of kaliemia. There are no known interactions with other drugs.
Rarely, during treatment, mild gastrointestinal disorders such as: abdominal heaviness, nausea and occasionally diarrhea.
The package in tablets can be particularly indicated in these subjects.
Conservation
Deadline for storage from the date of production, in integral packaging: 24 months.
Format
The package contains:
- 1 bottle of 60 tablets A
- 1 bottle of 60 tablets B.
Cod. 01016
